• Thu, November 11, 2021
Andrew Fein Maintained (ZNTL) at Strong Buy with Increased Target to $120 on, Nov 11th, 2021
Andrew Fein of HC Wainwright & Co., Maintained "Zentalis Pharmaceuticals, Inc." (ZNTL) at Strong Buy with Increased Target from $80 to $120 on, Nov 11th, 2021.
Andrew has made no other calls on ZNTL in the last 4 months.
There are 3 other peers that have a rating on ZNTL. Out of the 3 peers that are also analyzing ZNTL, 0 agree with Andrew's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Andrew
- Robert Driscoll of "Wedbush" Maintained at Buy with Increased Target to $89 on, Wednesday, October 27th, 2021
- Bradley Canino of "Stifel" Initiated at Strong Buy and Held Target at $84 on, Thursday, September 30th, 2021
- Matthew Biegler of "Oppenheimer" Initiated at Buy and Held Target at $90 on, Wednesday, September 29th, 2021
Like: 👍
